Provided by Tiger Fintech (Singapore) Pte. Ltd.

Biohaven Pharmaceutical Holding Co Ltd.

20.37
+1.699.05%
Post-market: 20.500.1300+0.64%19:18 EDT
Volume:2.10M
Turnover:41.81M
Market Cap:2.08B
PE:-2.20
High:20.51
Open:18.99
Low:18.50
Close:18.68
Loading ...
Mar 04, 2020

Major Issues Report

Current report, items 4.01 and 9.01
Feb 28, 2020

Major Issues Report

8-K - Current report
Feb 26, 2020

Annual Report

Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 26, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 10, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 10, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 10, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Feb 07, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Jan 31, 2020

Major Issues Report

Current report, items 5.02, 7.01, and 9.01
Jan 30, 2020

Major Issues Report

Current report, items 8.01 and 9.01
Jan 13, 2020

Major Issues Report

Current report, items 7.01 and 9.01
Nov 01, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Nov 01, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Oct 25, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Oct 17, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Oct 03, 2019

Major Issues Report

Current report, items 7.01 and 9.01
Sep 19, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Sep 13, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Sep 04, 2019

Major Issues Report

Current report, items 7.01 and 9.01